Budgeting
Organizations that can better predict volumes and react to changes will have a competitive advantage in the industry.
With benefits costs expected to climb 5% in 2020, employers are engaging in efforts to stem the increases.
While the outlook for the rest of the year remains positive, global economic uncertainty is causing a conservative investment approach.
Real-time tracking technologies allow the organization to monitor everything from patients to medical equipment.
Medical costs in the U.S. will rise more slowly compared to other regions, with Latin America, Africa and the Middle East seeing the most change.
Revenue growth remained a hurdle due to hospitals' ongoing reimbursement challenges, but overall stability has increased.
Changes to Medicare's post-hospital payment structure, to bring it closer to that used by private insurers, might save money, Health Affairs says.
Following two years of falling margins, the trend has reversed course, with median margins improving more than 10% over 2018.
From 1980 through 2018, the FDA approved a total of 126 cancer drugs to treat solid and hematologic tumors.
These improvements don't necessarily translate to sufficient margins, however, as hospitals in many markets are still struggling.